Multidimensional analysis and therapeutic development using patient iPSC–derived disease models of Wolfram syndrome
Wolfram syndrome is a rare genetic disorder largely caused by pathogenic variants in the WFS1 gene and manifested by diabetes mellitus, optic nerve atrophy, and progressive neurodegeneration. Recent genetic and clinical findings have revealed Wolfram syndrome as a spectrum disorder. Therefore, a gen...
Main Authors: | Rie Asada Kitamura, Kristina G. Maxwell, Wenjuan Ye, Kelly Kries, Cris M. Brown, Punn Augsornworawat, Yoel Hirsch, Martin M. Johansson, Tzvi Weiden, Joseph Ekstein, Joshua Cohen, Justin Klee, Kent Leslie, Anton Simeonov, Mark J. Henderson, Jeffrey R. Millman, Fumihiko Urano |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical investigation
2022-09-01
|
Series: | JCI Insight |
Subjects: | |
Online Access: | https://doi.org/10.1172/jci.insight.156549 |
Similar Items
-
A phase Ib/IIa clinical trial of dantrolene sodium in patients with Wolfram syndrome
by: Damien Abreu, et al.
Published: (2021-08-01) -
Localized T3 production modifies the transcriptome and promotes the hepatocyte-like lineage in iPSC-derived hepatic organoids
by: Jorge Hidalgo-Álvarez, et al.
Published: (2023-12-01) -
The Role of ER Stress in Diabetes: Exploring Pathological Mechanisms Using Wolfram Syndrome
by: Shuntaro Morikawa, et al.
Published: (2022-12-01) -
Applications of iPSC-derived beta cells from patients with diabetes
by: Kristina G. Maxwell, et al.
Published: (2021-04-01) -
Comparative and integrative single cell analysis reveals new insights into the transcriptional immaturity of stem cell-derived β cells
by: Mason D. Schmidt, et al.
Published: (2024-01-01)